Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2003-03-06
2008-12-16
Rao, Deepak (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C514S255050, C514S275000, C544S122000, C544S331000
Reexamination Certificate
active
07465728
ABSTRACT:
Compounds of the formula (I): wherein R1, R2, R3, R4, R5and p are as defined within and a pharmaceutically acceptable salts and in vivo hydrolysable esters are described. Also described are processes for their preparation and their use as medicaments, particularly medicaments for producing a cell cycle inhibitory (anti-cell-proliferation) effect in a warm-blooded animal, such as man.
REFERENCES:
patent: 4983608 (1991-01-01), Effland et al.
patent: 5516775 (1996-05-01), Zimmermann et al.
patent: 5521184 (1996-05-01), Zimmermann
patent: 5610303 (1997-03-01), Kimura et al.
patent: 5739143 (1998-04-01), Adams et al.
patent: 5859041 (1999-01-01), Liverton et al.
patent: 6835726 (2004-12-01), Cushing et al.
patent: 6908920 (2005-06-01), Thomas et al.
patent: 6969714 (2005-11-01), Breault et al.
patent: 2003/0144303 (2003-07-01), Hawley et al.
patent: 2003/0191307 (2003-10-01), Blumenkopf et al.
patent: 2004/0102630 (2004-05-01), Brumby et al.
patent: 2004/0224966 (2004-11-01), Brumby et al.
patent: 2005/0176743 (2005-08-01), Luecking et al.
patent: 2006/0079543 (2006-04-01), Sum et al.
patent: 2006/0111378 (2006-05-01), Cleve et al.
patent: 2231765 (1998-09-01), None
patent: 0 135 472 (1985-03-01), None
patent: 0 363 002 (1990-04-01), None
patent: 0 379 806 (1990-08-01), None
patent: 0 945 443 (1999-09-01), None
patent: 1056742 (2003-07-01), None
patent: 220630 (2002-03-01), None
patent: 91/18887 (1991-12-01), None
patent: 92/20642 (1992-11-01), None
patent: 95/09847 (1995-04-01), None
patent: 95/09851 (1995-04-01), None
patent: 95/09852 (1995-04-01), None
patent: 95/09853 (1995-04-01), None
patent: 95/15952 (1995-06-01), None
patent: 96/05177 (1996-02-01), None
patent: 96/28427 (1996-09-01), None
patent: 96/40143 (1996-12-01), None
patent: 97/19065 (1997-05-01), None
patent: 97/40017 (1997-10-01), None
patent: 97/44326 (1997-11-01), None
patent: 97/47618 (1997-12-01), None
patent: 98/11095 (1998-03-01), None
patent: 98/16230 (1998-04-01), None
patent: 98/18782 (1998-05-01), None
patent: 98/33798 (1998-08-01), None
patent: 98/41512 (1998-09-01), None
patent: 98/54093 (1998-12-01), None
patent: 98/56788 (1998-12-01), None
patent: 99/01136 (1999-01-01), None
patent: 99/32121 (1999-01-01), None
patent: 99/18096 (1999-04-01), None
patent: 99/18942 (1999-04-01), None
patent: 99/31073 (1999-06-01), None
patent: 99/41253 (1999-08-01), None
patent: 99/50250 (1999-10-01), None
patent: 99/50251 (1999-10-01), None
patent: 00/12485 (2000-03-01), None
patent: 00/12486 (2000-03-01), None
patent: 00/17202 (2000-03-01), None
patent: 00/17203 (2000-03-01), None
patent: 00/21926 (2000-04-01), None
patent: 00/25780 (2000-05-01), None
patent: 00/26209 (2000-05-01), None
patent: 00/39101 (2000-06-01), None
patent: 00/44750 (2000-08-01), None
patent: 00/49018 (2000-08-01), None
patent: 00/53595 (2000-09-01), None
patent: 00/55161 (2000-09-01), None
patent: 00/59892 (2000-10-01), None
patent: 00/78731 (2000-12-01), None
patent: 01/29009 (2001-04-01), None
patent: 01/30778 (2001-05-01), None
patent: 01/37835 (2001-05-01), None
patent: 01/47897 (2001-07-01), None
patent: 01/47921 (2001-07-01), None
patent: 01/60816 (2001-08-01), None
patent: 01/64653 (2001-09-01), None
patent: 01/64654 (2001-09-01), None
patent: 01/64655 (2001-09-01), None
patent: 01/64656 (2001-09-01), None
patent: 02/04429 (2002-01-01), None
patent: 02/20512 (2002-03-01), None
patent: WO 02/46170 (2002-06-01), None
patent: WO 02/46171 (2002-06-01), None
patent: 02/066481 (2002-08-01), None
patent: WO 02/065979 (2002-08-01), None
patent: WO 02/066480 (2002-08-01), None
patent: WO 02/092573 (2002-11-01), None
patent: 02/096887 (2002-12-01), None
patent: WO 02/096888 (2002-12-01), None
patent: 03/007955 (2003-01-01), None
patent: WO 03/011837 (2003-02-01), None
patent: WO 03/029249 (2003-04-01), None
patent: WO 03/031446 (2003-04-01), None
patent: WO 03/037891 (2003-05-01), None
patent: 03/076433 (2003-09-01), None
patent: 03/076434 (2003-09-01), None
patent: 03/076435 (2003-09-01), None
patent: WO 2004/005283 (2004-01-01), None
patent: WO 2004/043467 (2004-05-01), None
patent: WO 2004/043953 (2004-05-01), None
patent: WO 2004/087698 (2004-10-01), None
patent: WO 2004/087699 (2004-10-01), None
patent: WO 2004/101549 (2004-11-01), None
patent: WO 2004/101564 (2004-11-01), None
patent: WO 2005/012298 (2005-02-01), None
patent: WO 2005/037800 (2005-04-01), None
patent: WO 2005/075461 (2005-08-01), None
patent: WO 2005/075468 (2005-08-01), None
patent: WO 2005/113550 (2005-12-01), None
patent: WO 2005/116025 (2005-12-01), None
patent: WO 2006/034872 (2006-04-01), None
patent: WO 2006/044509 (2006-04-01), None
patent: WO 2006/050076 (2006-05-01), None
patent: WO 2006/064251 (2006-06-01), None
patent: WO 2006/075152 (2006-07-01), None
patent: WO 2006/095159 (2006-09-01), None
patent: WO 2007/015064 (2007-02-01), None
patent: WO 2007/036732 (2007-04-01), None
patent: WO 2007/040440 (2007-04-01), None
patent: WO 2007/138268 (2007-12-01), None
patent: WO 2007/138277 (2007-12-01), None
patent: WO 2007/148070 (2007-12-01), None
Traxler, Protein tyrosine kinase inhibitors in cancer treatment, Expert Opinion on Therapeutic Patents, 7(6), pp. 571-588, 1997.
Lu Valle et al., Cell Cycle Control in Growth Plate Chondrocytes, Frontiers in Biosciences 5, d493-503, May 2000.
Boschelli et al., Synthesis and Tyrosine Kinase Inhibitory Activity of a Series of 2-Amino-8-H-pyrido[2,3-d]pyrimidines: Identification of Potent, Selective Platelet-Derived Growth Factor Receptor Tyrosine Kinase Inhibitors, J. Med. Chem., vol. 41, 1998, pp. 4365-4377.
Deady et al., “Reactions of some Quinazoline Compounds with Ethoxymethylenemalonic Acid Derivatives”, J. Heterocyclic Chem., vol. 26, 1989, pp. 161-168.
El-Kerdawy et al.; “2,4-Bis (Substituted)-5-Nitropyrimidines of Expected Diuretic Action”; Egypt J. Chem. vol. 29, No. 2, 1986, pp. 247-251.
Fiziol Akt Veshchestva, 1975, vol. 7, pp. 68-72.
Ghosh et al.; “2,4-Bis(arylamino)-5-methylpyrimidines as Antimicrobial Agents”; J. Med. Chem., 1967, vol. 10, No. 5, pp. 974-975.
Ghosh, “2,4-Bis(Arylamino)-6-Methyl Pyrimidines as Antimicrobial Agents”, J. Indian Chem. Soc., vol. 58, No. 5, 1981, pp. 512-513.
Schmidt et al.; “A Convenient Synthesis of 2-substituted 4-Amino-5-pyrimidinecarbonitriles”; J. Heterocycle Chem., 1997, vol. 24, No. 5, pp. 1305-1307.
Zimmermann et al., Phenylamino-Pyrimidine (PAP) Derivatives: A New Class of Potent and Selective Inhibitors of Protein Kinase C (PKC), Arch. Pharm. Pharm. Med. Chem., vol. 329, 1996, pp. 371-376.
Blain et al. “Differential Interaction of the Cyclin-dependent Kinase (Cdk) Inhibitor p27Kip1 with Cyclin A-Cdk2 and Cyclin D2-Cdk4” J. Biol. Chem. 272(41):25863-25872 (1997).
Simone, Oncology: Introduction, Cecil Textbook of Medicine, 20th Edition, vol. 1, pp. 1004-1010 (1996).
Volin et al. “Cell cycle implications in the pathogenesis of rheumatoid arthritis” Frontiers in Bioscience 5: D594-601(2000).
Fiziol Akt Veshchestva 7:68-72 (1975) (Translation enclosed).
Newcombe Nicholas John
Thomas Andrew Peter
AstraZeneca AB
Morgan & Lewis & Bockius, LLP
Rao Deepak
LandOfFree
Derivatives of... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Derivatives of..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Derivatives of... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4030441